Severe group (N = 59) | Mild-Moderate group (N = 32) | P-Value | |
---|---|---|---|
Age, year, mean (SD) | 47.02 (13.11) | 49.50 (14.10) | 0.40 |
Male, n (%) | 37 (62.71) | 18 (56.25) | 0.547 |
Disease duration of UC, years (SD) | 4.19 (4.97) | 5.47 (8.08) | 0.42 |
Newly diagnosed cases (%) | 9 (15.25) | 2 (6.25) | 0.208 |
Hospital stay length, days (SD) | 15.58 (11.58) | 5.25 (3.88) | < 0.001 |
Frequency of bowel movements, times/day (SD) | 6.66 (3.86) | 2.16 (1.68) | < 0.001 |
Hematochezia, n (%) | 55 (93.22) | 12 (37.5) | < 0.001 |
WBC count, *10^9/L, (SD) | 8.01 (3.02) | 6.05 (2.20) | < 0.001 |
Hemoglobin, g/L, (SD) | 109.14 (24.80) | 135.16 (19.17) | < 0.001 |
Hct, %, (SD) | 33.98 (6.85) | 40.97 (4.74) | < 0.001 |
Platelet count, *10^9/L, (SD) | 327.17 (110.98) | 229.31 (63,07) | < 0.001 |
C-reactive protein, mg/L, (SD) | 45.04 (51.89) | 3.08 (6.37) | < 0.001 |
ESR, mm/h, (SD) | 27.15 (21.44) | 7.53 (5.83) | < 0.001 |
D-dimer, µg/L, (SD) | 1740.27 (3724.00) | 798.20 (2019.04) | 0.189 |
Fecal Calprotectin (μg/g) | N = 36 | N = 15 | |
323.88 (285.57) | 195.55 (315.50) | 0.162 | |
Albumin, g/L, (SD) | 34.95 (5.65) | 42.25 (5.10) | < 0.001 |
Current therapy by 5-ASA (%) | 49 (83.05) | 28 (87.5) | 0.797 |
Current corticosteroids drugs (%) | 8 (13.56) | 3 (9.38) | 0.804 |
Current anti-TNF treatment (%) | 1 (1.69) | 0 (0) | 1.000 |